Purchase Order N3239818P0003
Award Date
9/30/18
Potential Completion Date
9/29/19
Potential Value
$1.9K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $92,973.52 firm fixed-price purchase order is for the delivery of QIAAMP DNA extraction kits. The award is not associated with a set-aside program. Qiagen is an established federal contractor, holding multiple indefinite delivery/indefinite quantity (IDIQ) contracts and blanket purchase...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
This is a $1,635 purchase order awarded by a U.S. government agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract does not have a set-aside designation. Qiagen provides a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics software, and...
This federal contract award was issued by the Headquarters Division of the Department of Justice (DOJ) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $100,000.00 firm fixed-price purchase order contract provides for the delivery of Qiagen's products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen has held several indefinite delivery contracts (IDCs) and...
The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
This is a federal purchase order contract award to Qiagen, LLC, a division of Qiagen N.V., by the U.S. Department of Defense's Bureau of Medicine and Surgery. The contract is for the purchase of QIAAMP DNA BLOOD KIT, 200UL and EZ1 DNA TISSUE KIT, 200UL at a firm fixed price of $102,022.09. The award date was July 27, 2015, and the ultimate completion date is August 1, 2016. This contract has no set-aside designation. Qiagen is an international provider of sample and assay technologies that has...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
This federal contract award is for laboratory equipment and supplies provided by Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, with a ceiling value of $27,785.90, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of June 17, 2016. This award is not associated with a set-aside program....